Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
GlaxoSmithKline Plenaxis Approved in USAAntineoplastic & immunomodulating agents
GlaxoSmithKline Plenaxis in Phase IIGenito urinary system & sex hormones
GlaxoSmithKline Plenaxis Approved in USA and EUAntineoplastic & immunomodulating agents
Bristol-Myers Squibb Plavix Approved in USACardiovascular system
Sanofi-aventis Plavix Approved in USACardiovascular system
Barr Laboratories Plan B discontinuedGenito urinary system & sex hormones
Titan Pivanex and docetaxel discontinuedAntineoplastic & immunomodulating agents
Titan Pivanex in Phase IIAntineoplastic & immunomodulating agents
Titan Pivanex in Phase IIAntineoplastic & immunomodulating agents
Miravant Medical Technologies PHOTREX Approved in USASensory organs
TorreyPines Therapeutics Phenserine discontinuedNervous system
CollaGenex Periostat MR once daily formulation Approved in USAAlimentary tract & metabolism
CollaGenex Periostat accomplished Phase IIIDermatologicals
Ferring PENTASA in Phase IIIAlimentary tract & metabolism
Ferring PENTASA accomplished Phase IIIAlimentary tract & metabolism
Schering-Plough PEG-INTRON in Phase IIIAntineoplastic & immunomodulating agents
Nektar Therapeutics PEG-AXOKINE in Phase IAlimentary tract & metabolism
Roche PEGASYS Approved in EUAnti-infectives for systemic use
Roche PEGASYS Approved in USA and EUAnti-infectives for systemic use
Enzon Pegamotecan discontinuedAntineoplastic & immunomodulating agents

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.